Nifty

:

24624.65

Sensex

:

78581.00

9.75 (0.04%)
152.05 (0.19%)

Login

Nifty
Sensex

:
:

24624.65
78581.00

9.75 (0.04%)
152.05 (0.19%)

Lyka Labs Ltd.

Pharmaceuticals & Drugs

Rating :

42/99

BSE: 500259 | NSE: LYKALABS

Watchlist

NSE BSE

69.99

05-Aug-2026

Open
High
Low
Previous Close

66.66
69.99
66.66
66.66

Volume
Traded Value (lacs)
52 Week High
52 Week Low

38739
2694249.06
111.89
44.1

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

250.54
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

297.54
N/A
2.71

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

1.55
-7.92
4.92

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

6.13
-
59.16

P:E (Median)

8 Years
5 Years
3 Years

-
7.97
-

P:BV (Average)

8 Years
5 Years
3 Years

4.48
11.38
4.48

EV:EBITDA (Average)

8 Years
5 Years
3 Years

155.66
102.61
164.05

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 28.03 30.52 -8.16% 30.73 32.92 -6.65% 32.97 41.16 -19.90% 29.18 30.11 -3.09%
Expenses 32.51 27.22 19.43% 28.81 27.84 3.48% 36.13 35.81 0.89% 25.79 26.05 -1.00%
EBITDA -4.48 3.30 - 1.91 5.09 -62.48% -3.16 5.34 - 3.39 4.05 -16.30%
EBIDTM -15.99% 10.81% 6.23% 15.45% -9.57% 12.98% 11.61% 13.47%
Other Income 0.51 0.82 -37.80% 1.26 0.87 44.83% 1.22 0.13 838.46% 0.67 0.62 8.06%
Interest 0.87 0.52 67.31% 0.82 0.62 32.26% 0.79 0.52 51.92% 0.85 0.65 30.77%
Depreciation 2.04 1.42 43.66% 2.08 1.75 18.86% 2.07 1.68 23.21% 2.03 1.68 20.83%
PBT -29.90 2.18 - 0.28 3.59 -92.20% -4.80 3.27 - 1.17 2.35 -50.21%
Tax -0.13 0.95 - 0.00 0.89 -100.00% -1.17 0.80 - 0.36 0.60 -40.00%
PAT -29.77 1.23 - 0.28 2.70 -89.63% -3.63 2.47 - 0.81 1.75 -53.71%
PATM -106.21% 4.03% 0.91% 8.20% -11.00% 6.01% 2.79% 5.81%
EPS -8.22 0.34 - 0.08 0.75 -89.33% -1.00 0.68 - 0.22 0.48 -54.17%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 28.03 33.43 -16.15% 30.73 33.80 -9.08% 36.66 41.16 -10.93% 33.02 30.11 9.66%
Expenses 34.48 29.34 17.52% 29.08 28.60 1.68% 39.20 36.20 8.29% 29.34 26.41 11.09%
EBITDA -6.45 4.08 - 1.65 5.19 -68.21% -2.54 4.95 - 3.69 3.71 -0.54%
EBIDTM -23.02% 12.22% 5.37% 15.37% -6.93% 12.03% 11.16% 12.31%
Other Income 0.61 0.82 -25.61% 1.16 0.83 39.76% 1.09 0.03 3,533.33% 0.63 0.56 12.50%
Interest 0.70 0.47 48.94% 0.82 0.61 34.43% 0.79 0.54 46.30% 0.85 0.65 30.77%
Depreciation 2.04 1.42 43.66% 2.16 1.83 18.03% 2.15 1.76 22.16% 2.11 1.76 19.89%
PBT -8.59 3.02 - -0.16 3.57 - -4.39 2.67 - 1.35 1.86 -27.42%
Tax -0.52 0.99 - -0.01 0.87 - -1.17 0.76 - 0.36 0.57 -36.84%
PAT -8.07 2.03 - -0.15 2.71 - -3.21 1.91 - 1.00 1.29 -22.48%
PATM -28.78% 6.07% -0.49% 8.00% -8.77% 4.65% 3.02% 4.28%
EPS -2.13 0.50 - 0.00 0.76 -100.00% -0.94 0.59 - 0.26 0.40 -35.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales - 120.91 134.70 106.40 80.59 164.35 62.26 40.74 41.18 41.68 78.01 Net Sales Growth - -10.24% 26.60% 32.03% -50.96% 163.97% 52.82% -1.07% -1.20% -46.57% Cost Of Goods Sold - 45.49 53.23 42.94 29.06 30.87 23.52 19.65 22.24 21.53 36.31 Gross Profit - 75.41 81.48 63.45 51.53 133.49 38.74 21.10 18.94 20.15 41.70 GP Margin - 62.37% 60.49% 59.63% 63.94% 81.22% 62.22% 51.79% 45.99% 48.34% 53.45% Total Expenditure - 123.31 117.28 91.84 64.99 66.85 47.84 43.96 40.27 42.20 56.24 Power & Fuel Cost - 4.24 3.90 3.92 3.57 3.88 2.91 2.52 2.22 1.80 1.84 % Of Sales - 3.51% 2.90% 3.68% 4.43% 2.36% 4.67% 6.19% 5.39% 4.32% 2.36% Employee Cost - 41.60 34.40 26.01 17.48 16.22 13.03 11.71 9.99 10.90 9.99 % Of Sales - 34.41% 25.54% 24.45% 21.69% 9.87% 20.93% 28.74% 24.26% 26.15% 12.81% Manufacturing Exp. - 4.92 5.22 4.49 5.04 4.13 2.89 3.07 1.27 1.06 1.20 % Of Sales - 4.07% 3.88% 4.22% 6.25% 2.51% 4.64% 7.54% 3.08% 2.54% 1.54% General & Admin Exp. - 13.28 10.83 8.72 7.11 5.62 3.78 4.30 3.86 3.40 2.76 % Of Sales - 10.98% 8.04% 8.20% 8.82% 3.42% 6.07% 10.55% 9.37% 8.16% 3.54% Selling & Distn. Exp. - 5.89 8.26 4.48 1.84 4.54 1.23 0.84 0.07 0.15 0.36 % Of Sales - 4.87% 6.13% 4.21% 2.28% 2.76% 1.98% 2.06% 0.17% 0.36% 0.46% Miscellaneous Exp. - 7.89 1.46 1.27 0.89 1.60 0.48 1.88 0.61 3.35 0.36 % Of Sales - 6.53% 1.08% 1.19% 1.10% 0.97% 0.77% 4.61% 1.48% 8.04% 4.83% EBITDA - -2.40 17.42 14.56 15.60 97.50 14.42 -3.22 0.91 -0.52 21.77 EBITDA Margin - -1.98% 12.93% 13.68% 19.36% 59.32% 23.16% -7.90% 2.21% -1.25% 27.91% Other Income - 3.97 2.76 1.65 3.45 2.72 2.21 2.60 2.66 1.89 1.71 Interest - 3.33 2.30 4.80 11.57 19.92 25.55 19.01 5.73 7.76 16.54 Depreciation - 8.46 6.77 12.29 13.52 15.39 8.05 7.77 4.44 6.31 5.53 PBT - -10.22 11.10 -0.88 -6.03 64.91 -16.97 -27.40 -6.59 -12.69 1.41 Tax - -0.95 3.18 1.34 0.08 20.34 -3.94 0.24 -8.83 -0.38 -0.37 Tax Rate - 2.86% 28.65% -142.55% -0.61% 33.76% 21.41% -0.44% 124.37% 3.39% 67.27% PAT - -32.29 7.92 -2.27 -13.29 39.90 -14.46 -55.39 1.73 -10.84 -0.19 PAT before Minority Interest - -32.29 7.92 -2.27 -13.29 39.90 -14.46 -55.39 1.73 -10.84 -0.19 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - -26.71% 5.88% -2.13% -16.49% 24.28% -23.23% -135.96% 4.20% -26.01% -0.24% PAT Growth - - - - - - - - - - EPS - -8.92 2.19 -0.63 -3.67 11.02 -3.99 -15.30 0.48 -2.99 -0.05

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales - 128.44 138.50 111.19 93.07 194.08 86.25 61.49 70.78 59.81 110.08 Net Sales Growth - -7.26% 24.56% 19.47% -52.05% 125.02% 40.27% -13.13% 18.34% -45.67% Cost Of Goods Sold - 50.20 55.59 44.85 37.55 52.97 37.97 34.42 39.25 29.38 53.85 Gross Profit - 78.25 82.90 66.34 55.52 141.11 48.28 27.07 31.54 30.43 56.23 GP Margin - 60.92% 59.86% 59.66% 59.65% 72.71% 55.98% 44.02% 44.56% 50.88% 51.08% Total Expenditure - 131.93 120.56 95.49 76.23 92.94 66.57 65.16 72.68 63.36 87.31 Power & Fuel Cost - 4.24 3.90 3.93 3.60 3.92 2.94 2.56 2.28 1.86 1.90 % Of Sales - 3.30% 2.82% 3.53% 3.87% 2.02% 3.41% 4.16% 3.22% 3.11% 1.73% Employee Cost - 41.85 34.63 26.77 18.61 18.06 14.57 13.86 14.69 16.98 17.24 % Of Sales - 32.58% 25.00% 24.08% 20.00% 9.31% 16.89% 22.54% 20.75% 28.39% 15.66% Manufacturing Exp. - 4.95 5.22 4.52 5.09 4.20 3.00 3.10 1.32 1.06 1.20 % Of Sales - 3.85% 3.77% 4.07% 5.47% 2.16% 3.48% 5.04% 1.86% 1.77% 1.09% General & Admin Exp. - 13.53 11.23 9.32 7.89 6.29 4.31 5.70 5.91 5.81 5.96 % Of Sales - 10.53% 8.11% 8.38% 8.48% 3.24% 5.00% 9.27% 8.35% 9.71% 5.41% Selling & Distn. Exp. - 8.15 8.43 4.70 2.59 5.75 2.65 2.27 5.17 2.95 0.37 % Of Sales - 6.35% 6.09% 4.23% 2.78% 2.96% 3.07% 3.69% 7.30% 4.93% 0.34% Miscellaneous Exp. - 9.01 1.55 1.41 0.90 1.74 1.14 3.24 4.07 5.31 0.37 % Of Sales - 7.01% 1.12% 1.27% 0.97% 0.90% 1.32% 5.27% 5.75% 8.88% 6.18% EBITDA - -3.49 17.94 15.70 16.84 101.14 19.68 -3.67 -1.90 -3.55 22.77 EBITDA Margin - -2.72% 12.95% 14.12% 18.09% 52.11% 22.82% -5.97% -2.68% -5.94% 20.68% Other Income - 3.50 2.23 1.46 3.40 2.09 1.56 3.09 2.09 2.13 2.24 Interest - 3.33 2.27 4.89 11.87 20.13 25.94 20.07 7.17 9.58 18.72 Depreciation - 8.46 6.77 12.80 14.15 17.35 8.32 8.01 7.31 11.28 10.25 PBT - -11.78 11.12 -0.52 -5.78 65.77 -13.02 -28.66 -14.29 -22.28 -3.97 Tax - -1.34 3.19 1.69 -0.02 20.80 -4.05 0.74 -9.07 -1.04 -1.51 Tax Rate - 11.38% 28.69% -181.72% 0.15% 35.11% 28.62% -1.20% 58.78% 5.19% 18.62% PAT - -10.04 8.01 -2.49 -13.21 39.00 -11.55 -60.54 -5.55 -17.21 -5.54 PAT before Minority Interest - -10.44 7.93 -2.62 -13.15 38.44 -10.09 -62.62 -6.35 -19.00 -6.60 Minority Interest - 0.40 0.08 0.13 -0.06 0.56 -1.46 2.08 0.80 1.79 1.06 PAT Margin - -7.82% 5.78% -2.24% -14.19% 20.09% -13.39% -98.46% -7.84% -28.77% -5.03% PAT Growth - - - - - - - - - - EPS - -2.77 2.21 -0.69 -3.65 10.77 -3.19 -16.72 -1.53 -4.75 -1.53

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 87.00 121.60 99.33 76.43 44.44 4.41 18.78 98.60 96.78 73.61 Share Capital 35.69 35.69 33.09 30.69 28.69 28.69 28.69 28.14 28.14 22.04 Total Reserves 50.85 85.45 57.17 28.30 15.75 -24.28 -9.91 69.71 67.89 51.57 Non-Current Liabilities 30.25 26.01 50.78 72.46 70.40 147.35 134.87 71.56 6.17 36.77 Secured Loans 13.86 9.72 7.18 0.00 0.00 150.35 125.05 77.90 3.84 34.64 Unsecured Loans 9.13 9.48 35.73 63.40 61.63 0.71 0.64 0.90 0.87 0.84 Long Term Provisions 3.35 0.63 1.74 2.13 2.44 2.68 2.83 2.77 2.54 2.20 Current Liabilities 53.50 45.06 35.91 29.97 93.68 45.39 55.34 68.29 140.46 131.37 Trade Payables 16.79 13.83 10.91 8.23 8.68 12.02 16.50 22.10 21.34 28.11 Other Current Liabilities 16.42 14.85 11.77 12.93 64.08 21.66 26.33 32.27 81.91 64.47 Short Term Borrowings 19.08 14.83 11.61 7.64 19.90 10.09 10.59 12.41 35.59 37.67 Short Term Provisions 1.21 1.55 1.62 1.17 1.02 1.62 1.91 1.51 1.62 1.13 Total Liabilities 170.75 192.67 186.02 178.86 208.52 197.15 208.99 238.45 243.41 241.75 Net Block 87.11 85.11 55.64 65.53 90.11 95.34 101.65 76.23 81.16 86.27 Gross Block 201.48 191.03 153.38 153.59 171.88 162.94 140.52 93.40 94.27 92.84 Accumulated Depreciation 114.37 105.91 97.73 88.07 81.76 67.60 38.87 17.17 13.11 6.58 Non Current Assets 110.29 122.53 136.15 136.56 161.32 171.41 178.29 189.43 190.17 193.96 Capital Work in Progress 1.88 1.20 23.05 16.23 17.74 24.40 26.40 29.71 26.43 24.23 Non Current Investment 0.00 14.71 32.40 32.40 32.40 32.40 32.40 62.45 62.45 62.45 Long Term Loans & Adv. 21.30 21.50 25.05 22.41 21.06 19.28 17.83 21.03 20.12 21.01 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 60.45 70.15 49.86 42.30 47.19 25.73 30.70 49.03 53.24 47.79 Current Investments 0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 Inventories 13.63 12.47 9.56 6.94 8.18 4.30 5.71 5.95 7.30 9.25 Sundry Debtors 32.91 40.45 25.73 17.16 17.59 9.90 6.59 29.68 30.26 24.22 Cash & Bank 1.19 1.33 5.89 8.70 15.38 6.53 8.40 0.09 0.47 1.46 Other Current Assets 12.69 6.87 2.76 2.32 6.03 5.00 9.99 13.31 15.22 12.86 Short Term Loans & Adv. 5.85 9.02 5.92 7.17 3.82 2.58 5.77 6.62 14.91 11.29 Net Current Assets 6.95 25.09 13.95 12.33 -46.48 -19.66 -24.64 -19.26 -87.22 -83.57 Total Assets 170.74 192.68 186.01 178.86 208.51 197.14 208.99 238.46 243.41 241.75

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 92.39 104.74 68.15 45.44 13.34 -25.80 -14.34 43.02 49.47 37.71 Share Capital 35.69 35.69 33.09 30.69 28.69 28.69 28.69 28.14 28.14 22.04 Total Reserves 56.24 68.59 26.00 -2.69 -15.35 -54.49 -43.03 14.12 20.57 15.67 Non-Current Liabilities 29.81 25.99 50.82 73.25 72.77 148.88 136.67 72.28 5.28 38.68 Secured Loans 13.86 9.72 7.18 0.39 0.86 150.65 125.45 78.39 4.06 34.93 Unsecured Loans 9.13 9.48 35.73 63.40 61.63 0.71 0.64 0.90 0.87 0.84 Long Term Provisions 3.35 0.65 1.82 2.44 3.47 3.66 3.86 4.08 3.63 4.39 Current Liabilities 53.90 46.63 37.77 32.60 99.35 49.88 66.32 84.81 167.12 165.45 Trade Payables 16.79 14.95 12.10 9.41 12.00 14.71 18.85 23.23 24.21 39.16 Other Current Liabilities 16.81 15.28 12.41 14.35 66.24 23.10 30.83 43.31 92.38 73.07 Short Term Borrowings 19.08 14.83 11.61 7.64 20.07 10.37 14.41 16.26 45.82 50.23 Short Term Provisions 1.21 1.56 1.65 1.20 1.05 1.70 2.23 2.02 4.72 2.99 Total Liabilities 174.54 176.20 156.85 151.52 185.61 173.66 187.88 202.85 225.23 248.87 Net Block 87.11 85.11 57.70 68.10 93.96 98.19 104.78 107.73 116.04 132.90 Gross Block 201.84 191.38 157.75 157.96 177.35 202.50 188.36 202.81 155.31 144.01 Accumulated Depreciation 114.73 106.27 100.05 89.87 83.40 104.31 83.58 95.08 39.27 11.11 Non Current Assets 111.26 108.77 106.20 107.32 133.42 144.59 152.00 167.75 176.16 186.07 Capital Work in Progress 1.88 1.20 23.05 16.23 17.74 25.76 27.76 31.07 27.88 24.23 Non Current Investment 0.00 0.02 0.07 0.04 0.01 0.01 0.01 0.01 0.23 0.26 Long Term Loans & Adv. 22.27 22.43 25.38 22.96 21.71 20.63 19.46 28.94 32.01 28.69 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 63.28 67.43 50.65 44.20 52.20 29.08 35.88 35.11 49.07 62.79 Current Investments 0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 Inventories 13.63 12.47 9.57 6.95 8.20 4.31 6.73 7.00 11.20 13.24 Sundry Debtors 35.03 43.08 26.99 20.13 18.45 8.67 8.04 14.63 20.50 29.17 Cash & Bank 1.36 1.34 5.95 11.71 17.05 7.15 10.30 1.71 2.43 5.12 Other Current Assets 13.23 6.47 3.34 2.93 8.49 8.94 10.80 11.77 14.95 15.25 Short Term Loans & Adv. 6.38 4.05 4.78 2.48 5.62 4.21 4.26 9.64 13.21 10.92 Net Current Assets 9.38 20.80 12.88 11.61 -47.15 -20.80 -30.44 -49.70 -118.05 -102.66 Total Assets 174.54 176.20 156.85 151.52 185.62 173.67 187.88 202.86 225.23 248.86

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 5.09 -1.62 3.09 6.87 76.53 5.75 -11.45 18.31 6.84 20.17 PBT -33.24 11.10 -0.93 -13.21 60.24 -18.40 -55.15 -7.10 -11.22 -0.56 Adjustment 41.58 8.00 16.66 31.31 37.60 33.97 54.79 10.34 11.81 22.16 Changes in Working Capital -2.78 -17.68 -11.16 -10.81 -20.76 -9.10 -11.85 15.30 6.69 -0.29 Cash after chg. in Working capital 5.56 1.42 4.56 7.29 77.08 6.47 -12.22 18.53 7.28 21.31 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.48 -3.03 -1.47 -0.41 -0.55 -0.72 0.77 -0.22 -0.44 -1.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 Cash From Investing Activity -9.42 -11.22 -8.61 6.77 -4.33 0.13 0.13 -2.94 -3.35 -5.25 Net Fixed Assets -11.13 -15.80 -6.61 19.80 -2.28 -20.42 -43.81 -2.41 -3.63 12.94 Net Investments 14.70 17.69 -0.01 0.00 0.00 0.00 30.05 -0.01 0.00 0.12 Others -12.99 -13.11 -1.99 -13.03 -2.05 20.55 13.89 -0.52 0.28 -18.31 Cash from Financing Activity 4.19 8.25 2.71 -20.33 -63.35 -7.75 19.61 -15.76 -4.48 -15.20 Net Cash Inflow / Outflow -0.14 -4.59 -2.81 -6.69 8.85 -1.88 8.28 -0.38 -0.99 -0.28 Opening Cash & Equivalents 1.33 5.91 8.70 15.38 6.53 8.40 0.12 0.47 1.46 1.73 Closing Cash & Equivalent 1.19 1.33 5.89 8.70 15.38 6.53 8.40 0.09 0.47 1.46

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 5.24 1.90 1.77 8.95 79.25 8.81 5.32 26.67 10.88 31.38 PBT -11.78 11.12 -0.93 -13.17 59.25 -14.14 -61.88 -15.42 -20.04 -8.10 Adjustment 19.83 8.46 18.02 31.78 41.93 35.40 55.76 15.17 20.79 30.53 Changes in Working Capital -2.50 -14.65 -13.80 -9.86 -21.01 -11.64 10.94 27.65 10.36 10.10 Cash after chg. in Working capital 5.55 4.93 3.29 8.75 80.16 9.62 4.82 27.39 11.10 32.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.31 -3.03 -1.52 0.20 -0.92 -0.81 0.50 -1.10 -0.44 -1.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.37 0.23 0.06 Cash From Investing Activity -9.41 -11.80 -9.49 7.35 -6.17 -0.16 -0.11 -3.97 -3.17 -12.67 Net Fixed Assets -11.13 -15.80 -6.61 19.80 -2.28 -20.42 -43.81 -2.41 -3.63 12.94 Net Investments 14.70 17.69 -0.01 0.00 0.00 0.00 30.05 -0.01 0.00 0.12 Others -12.98 -13.69 -2.87 -12.45 -3.89 20.26 13.65 -1.55 0.46 -25.73 Cash from Financing Activity 4.19 5.29 1.95 -21.64 -63.18 -11.80 3.38 -23.42 -10.41 -19.15 Net Cash Inflow / Outflow 0.02 -4.60 -5.76 -5.34 9.90 -3.15 8.60 -0.72 -2.69 -0.43 Opening Cash & Equivalents 1.34 5.95 11.71 17.05 7.15 10.30 1.71 2.43 5.12 5.56 Closing Cash & Equivalent 1.36 1.34 5.95 11.71 17.05 7.15 10.30 1.70 2.43 5.12

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 24.25 33.94 27.28 19.22 15.49 1.54 6.55 34.77 34.12 33.40 ROA -17.77% 4.18% -1.24% -6.86% 19.67% -7.12% -24.76% 0.72% -4.47% -0.08% ROE -31.09% 7.49% -3.04% -25.69% 163.37% -124.71% -94.98% 1.79% -12.78% -0.27% ROCE -20.28% 8.50% 2.54% -1.02% 47.25% 4.45% -20.89% -0.70% -1.80% 9.01% Fixed Asset Turnover 0.62 0.78 0.69 0.50 0.98 0.41 0.35 0.44 0.45 0.88 Receivable days 110.74 89.66 73.57 78.69 30.52 48.35 162.49 265.62 233.98 108.50 Inventory Days 39.39 29.84 28.30 34.25 13.86 29.33 52.19 58.69 71.09 34.72 Payable days 122.85 84.82 81.33 106.20 122.42 221.30 152.63 195.00 214.53 192.84 Cash Conversion Cycle 27.28 34.68 20.54 6.74 -78.04 -143.63 62.05 129.31 90.54 -49.62 Total Debt/Equity 0.56 0.31 0.63 1.21 2.90 36.68 7.29 0.94 1.06 1.53 Interest Cover -8.99 5.82 0.81 -0.14 4.02 0.28 -1.90 -0.24 -0.45 0.97

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 25.76 29.22 17.86 9.12 4.65 -8.99 -5.00 15.02 16.78 15.82 ROA -5.95% 4.76% -1.70% -7.80% 21.40% -5.58% -32.05% -2.97% -8.02% -2.70% ROE -10.64% 9.71% -6.02% -63.63% 0.00% 0.00% -448.65% -14.20% -46.30% -18.27% ROCE -5.96% 10.01% 3.26% -1.00% 56.68% 8.95% -31.39% -5.50% -6.52% 6.66% Fixed Asset Turnover 0.65 0.79 0.70 0.56 1.02 0.44 0.31 0.40 0.41 0.68 Receivable days 110.99 92.33 77.33 75.65 25.51 35.37 67.29 90.56 149.54 113.31 Inventory Days 37.08 29.04 27.12 29.71 11.76 23.36 40.77 46.92 73.58 37.61 Payable days 115.42 88.82 87.52 104.00 92.01 161.35 117.58 127.84 181.43 174.53 Cash Conversion Cycle 32.64 32.55 16.94 1.36 -54.74 -102.62 -9.53 9.65 41.69 -23.60 Total Debt/Equity 0.53 0.36 0.96 2.58 9.76 -6.30 -9.85 2.28 2.39 3.60 Interest Cover -2.54 5.90 0.81 -0.11 3.94 0.45 -2.08 -1.15 -1.09 0.57

Top Investors:

thermo capital private limited

dalal & broacha stock broking pvt.ltd.

Annual Reports:

News Update:

Lyka Labs - Quarterly Results
26th May 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback